Status:
ACTIVE_NOT_RECRUITING
Westlake Precision Birth Cohort
Lead Sponsor:
Westlake University
Collaborating Sponsors:
Hangzhou Maternal and Child Health Hospital
Conditions:
Diabetes, Gestational
Pregnancy in Diabetics
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The Westlake Precision Birth Cohort (WeBirth) is a prospective cohort study among women with hyperglycemia during pregnancy and their offspring living in Hangzhou, China. The primary aim of this cohor...
Detailed Description
In China, an alarming increase in the prevalence of GDM has been observed in the past decade. GDM is of concern because it is associated with several maternal and fetal medical disorders. Lifestyle ch...
Eligibility Criteria
Inclusion
- Women aged 18 years or older
- Women with GDM at 24-28 weeks of gestation
- Women intended to deliver at Hangzhou Women's Hospital
- Women intended to remain in Hangzhou with their child for ≥4 years
Exclusion
- ● Women with cancer and other serious medical disorders
Key Trial Info
Start Date :
August 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2029
Estimated Enrollment :
2001 Patients enrolled
Trial Details
Trial ID
NCT04060056
Start Date
August 30 2019
End Date
August 31 2029
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hangzhou Women's Hospital
Hangzhou, Zhejiang, China, 310030